Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 2
1984 3
1985 2
1986 4
1987 3
1988 1
1989 1
1990 1
1991 2
1992 4
1993 6
1994 9
1995 16
1996 6
1997 18
1998 9
1999 12
2000 19
2001 9
2002 21
2003 40
2004 60
2005 62
2006 82
2007 100
2008 117
2009 161
2010 204
2011 206
2012 220
2013 262
2014 279
2015 367
2016 402
2017 427
2018 447
2019 506
2020 572
2021 590
2022 745
2023 789
2024 343

Text availability

Article attribute

Article type

Publication date

Search Results

6,311 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Wang ML, et al. N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. N Engl J Med. 2022. PMID: 35657079 Clinical Trial.
Ultrasound-augmented cancer immunotherapy.
Liu B, Du F, Feng Z, Xiang X, Guo R, Ma L, Zhu B, Qiu L. Liu B, et al. Among authors: qiu l. J Mater Chem B. 2024 Apr 17;12(15):3636-3658. doi: 10.1039/d3tb02705h. J Mater Chem B. 2024. PMID: 38529593 Review.
Hodgkin's lymphoma: 2023 update on treatment.
Zhang S, Liu X, Li L, Qiu L, Qian Z, Zhou S, Wang X, Zhang H. Zhang S, et al. Among authors: qiu l. Cancer Biol Med. 2023 Dec 29;21(4):269-73. doi: 10.20892/j.issn.2095-3941.2023.0427. Cancer Biol Med. 2023. PMID: 38164723 Free PMC article. No abstract available.
Targeting gut microbial nitrogen recycling and cellular uptake of ammonium to improve bortezomib resistance in multiple myeloma.
Zhu Y, Jian X, Chen S, An G, Jiang D, Yang Q, Zhang J, Hu J, Qiu Y, Feng X, Guo J, Chen X, Li Z, Zhou R, Hu C, He N, Shi F, Huang S, Liu H, Li X, Xie L, Zhu Y, Zhao L, Jiang Y, Li J, Wang J, Qiu L, Chen X, Jia W, He Y, Zhou W. Zhu Y, et al. Among authors: qiu l. Cell Metab. 2024 Jan 2;36(1):159-175.e8. doi: 10.1016/j.cmet.2023.11.019. Epub 2023 Dec 18. Cell Metab. 2024. PMID: 38113887 Free article.
Intratumoral CD103+ CD8+ T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma.
Ren S, Lan T, Wu F, Chen S, Jiang X, Huo C, Li Z, Xie S, Wu D, Wang R, Li Y, Qiu L, Huang G, Li S, Wang X, Cen M, Cai T, Lin Z, Li J, Li B. Ren S, et al. Among authors: qiu l. Cancer Commun (Lond). 2023 Oct;43(10):1143-1163. doi: 10.1002/cac2.12480. Epub 2023 Sep 1. Cancer Commun (Lond). 2023. PMID: 37658605 Free PMC article.
Expert consensus on digital guided therapy for endodontic diseases.
Wei X, Du Y, Zhou X, Yue L, Yu Q, Hou B, Chen Z, Liang J, Chen W, Qiu L, Huang X, Meng L, Huang D, Wang X, Tian Y, Tang Z, Zhang Q, Miao L, Zhao J, Yang D, Yang J, Ling J. Wei X, et al. Among authors: qiu l. Int J Oral Sci. 2023 Dec 6;15(1):54. doi: 10.1038/s41368-023-00261-0. Int J Oral Sci. 2023. PMID: 38052782 Free PMC article. Review.
Steroid profiling in adrenal disease.
Mu D, Sun D, Qian X, Ma X, Qiu L, Cheng X, Yu S. Mu D, et al. Among authors: qiu l. Clin Chim Acta. 2024 Jan 15;553:117749. doi: 10.1016/j.cca.2023.117749. Epub 2023 Dec 31. Clin Chim Acta. 2024. PMID: 38169194 Review.
6,311 results